한빛사163건

• • 김성룡(KAIST)

  • 전지향(질병관리청)

  • 박종은(KAIST)

  • 여진아(질병관리청)

  Innate immune responses against mRNA vaccine promote cellular immunity through IFN-β at the injection site

  • Nat. Commun. 27 August 2024 | https://doi.org/10.1038/s41467-024-51411-9

  • 2024.08

• • 유민희(안전성평가연구소)

  • 김용범(안전성평가연구소)

  Potential of 6‘?hydroxy justicidin B from Justicia procumbens as a therapeutic agent against coronavirus disease 2019

  • Phytomedicine Aug 31 2024, 134 S0944-7113(24)00671-8 | https://doi.org/10.1016/j.phymed.2024.156014

  • 2024.08
  • 의약학

• • 신호정(서울대학교)

  • 민달희(서울대학교)

  A Single-Dose mRNA Vaccine Employing Porous Silica Nanoparticles Induces Robust Immune Responses Against the Zika Virus

  • Adv. Sci. Jul 15 2024, | https://doi.org/10.1002/advs.202404590

  • 2024.07
  • 바이오·의료융합

• • 정승원(연세대학교)

  • 전재준(연세대학교)

    Interview

  • 최승재(연세대학교, 현 갤러리아피부과의원 반포본점)

  • 이솔암(연세대학교)

  Long-term risk of autoimmune diseases after mRNA-based SARS-CoV2 vaccination in a Korean, nationwide, population-based cohort study

  • Nat. Commun. 23 July 2024 | https://doi.org/10.1038/s41467-024-50656-8

  • 2024.07
  • 의약학

• • 정이든(경희대학교)

  • 이경민(경희대학교)

  • 이수지(경희대학교)

  • 여승근(경희대학교)

  • 이하연(경희대학교)

  • 연동건(경희대학교 의과대학, 경희의료원)

  Global and regional burden of vaccine-associated facial paralysis, 1967-2023: Findings from the WHO international pharmacovigilance database

  • J. Med. Virol. Jun 2024, 96 (6) | https://doi.org/10.1002/jmv.29682

  • 2024.06
  • 바이오·의료융합

• • 오상익(농촌진흥청, 전북대학교)

    Interview

  • Sunirmal Sheet(농촌진흥청)

  • 이후석(충남대학교)

  • 조아라(농촌진흥청)

  • 임다정(농촌진흥청, 충남대학교)

  Transcriptome profiles of organ tissues from pigs experimentally infected with African swine fever virus in early phase of infection

  • Emerg. Microbes Infect. Jun 07 2024, | https://doi.org/10.1080/22221751.2024.2366406

  • 2024.06
  • 생명과학

• • 배서현(가톨릭대학교)

  • 유소연(한국과학기술연구원)

  • 이지선(가톨릭대학교)

  • 박효정(가톨릭대학교)

  • 윤혜원(서울대학교병원)

  • 남재환(가톨릭대학교)

  • 방은경(한국과학기술연구원)

  A lipid nanoparticle platform incorporating trehalose glycolipid for exceptional mRNA vaccine safety

  • Bioact. Mater. 2024 May 14:38:486-498 | https://doi.org/10.1016/j.bioactmat.2024.05.012

  • 2024.05
  • 바이오·의료융합

• • 박홍재(Yale University School of Medicine)

  • 강인수(Yale University School of Medicine)

  IL-1 receptor 1 signaling shapes the development of viral antigen-specific CD4+ T cell responses following COVID-19 mRNA vaccination

  • EBioMedicine Volume 103, May 2024, 105114 | https://doi.org/10.1016/j.ebiom.2024.105114

  • 2024.05
  • 생명과학

• • 노지훈(고려대학교 의과대학 / 고대안암병원)

  A potential association between COVID-19 vaccination and development of alzheimer‘s disease

  • QJM-An Int. J. Med. May 28 2024, hcae103 | https://doi.org/10.1093/qjmed/hcae103

  • 2024.05
  • 의약학

• • 이정현(The Scripps Research Institute)

  Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice

  • Sci. Transl. Med. May 22 2024, | https://doi.org/10.1126/scitranslmed.adn0223

  • 2024.05

• • James J. Moon(University of Michigan)

  Self-Assembled STING-Activating Coordination Nanoparticles for Cancer Immunotherapy and Vaccine Applications

  • ACS Nano Apr 16 2024, 18 (15) | https://doi.org/10.1021/acsnano.3c11374

  • 2024.04

• • 한지훈(고려대학교, KIST)

  • 김서현(고려대학교, KIST, 시프트바이오)

  • 김인산(고려대학교, KIST)

  Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity

  • Adv. Sci. Apr 26 2024, | https://doi.org/10.1002/advs.202308662

  • 2024.04
  • 바이오·의료융합

• • 김재덕(가톨릭대학교 의과대학)

  • 이아라(가톨릭대학교 의과대학)

  • 성백린(연세대학교 의과대학)

  • 서상욱(가톨릭대학교 의과대학)

  Efficacy of Genotype-matched Vaccine Against Re-emerging Genotype V Japanese Encephalitis Virus

  • Emerg. Microbes Infect. Apr 15 2024, | https://doi.org/10.1080/22221751.2024.2343910

  • 2024.04
  • 생명과학

• • 한충민(POSTECH)

  • 박재성(POSTECH, University of Michigan)

  Cell-engineered virus-mimetic nanovesicles for vaccination against enveloped viruses

  • J. Extracell. Vesicles Apr 2024, 13 (4) e12438 | https://doi.org/10.1002/jev2.12438

  • 2024.04
  • 바이오·의료융합

• • 김홍진(인제대학교 상계백병원)

  • 김민호(이화여자대학교)

  • 천은미(이화여자대학교)

  Autoimmune adverse event following COVID-19 vaccination in Seoul, South Korea

  • J. Allergy Clin. Immunol. Mar 18 2024, S0091-6749(24)00129-5 | https://doi.org/10.1016/j.jaci.2024.01.025

  • 2024.03
  • 의약학

• • 김소희(서울대학교)

  • 김유리(서울대학교 의과대학)

  • 전상은(한국파스퇴르연구소)

  • 김승택(한국파스퇴르연구소)

  • 김연숙(충남대학교 의과대학)

  • 임동균(국립중앙의료원)

  • 조남혁(서울대학교)

  Rise in broadly cross-reactive adaptive immunity against human β-coronaviruses in MERS-recovered patients during the COVID-19 pandemic

  • Sci. Adv. Mar 2024, 10 (9) | https://doi.org/10.1126/sciadv.adk6425

  • 2024.03
  • 의약학

• • 박진균(서울대학교 의과대학)

  What rheumatologists need to know about mRNA vaccines: current status and future of mRNA vaccines in autoimmune inflammatory rheumatic diseases

  • Ann. Rheum. Dis. Feb 27 2024, ard-2024-225492 | https://doi.org/10.1136/ard-2024-225492

  • 2024.02

• • 박재영(Georgia Institute of Technology)

    Interview

  Development of Self-Assembled Protein Nanocage Spatially Functionalized with HA Stalk as a Broadly Cross-Reactive Influenza Vaccine Platform

  • ACS Nano Dec 12 2023, | https://doi.org/10.1021/acsnano.3c07669

  • 2023.12
  • 생명과학
• 

  박재영

  Georgia Institute of Technology

  인플루엔자는 자주 변이되는 바이러스이기 때문에 매년 업데이트되는 인플루엔자 백신으로는 효과적인 전염 방지에 한계가 있습니다. 변이된 인플루엔자 아형들에 반응하는 백신을 만들기 위해서는 highly conserved antigen으로 백신 formulation을 해야 되지만 이러한 antigen들은 면역원성(immunogenicity)이 약한 단점이 있습니다.

  • ACS Nano
  • 2023.12.26

• • James J. Moon(University of Michigan)

  Vaccines for immune tolerance against autoimmune disease

  • Adv. Drug Deliv. Rev. Nov 18 2023, 203 S0169-409X(23)00455-6 | https://doi.org/10.1016/j.addr.2023.115140

  • 2023.11